Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The tenascins are a family of large extracellular matrix proteins with at least three members: tenascin-X (TNX), tenascin-C (TNC, or cytotactin) and tenascin-R (TN-R, or restrictin). Although the tenascins have been implicated in a number of important cellular processes, no function has been clearly established for any tenascin. We describe a new contiguous-gene syndrome, involving the CYP21B and TNX genes, that results in 21-hydroxylase deficiency and a connective-tissue disorder consisting of skin and joint hyperextensibility, vascular fragility and poor wound healing. The connective tissue findings are typical of the Ehlers-Danlos syndrome (EDS). The abundant expression of TNX in connective tissues is consistent with a role in EDS, and our patient's skin fibroblasts do not synthesize TNX protein in vitro or in vivo. His paternal allele carries a novel deletion arising from recombination between TNX and its partial duplicate gene, XA, which precludes TNX synthesis. Absence of TNX mRNA and protein in the proband, mapping of the TNX gene and HLA typing of this family suggest recessive inheritance of TNX deficiency and connective-tissue disease. Although the precise role of TNX in the pathogenesis of EDS is uncertain, this patient's findings suggest a unique and essential role for TNX in connective-tissue structure and function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This rare chimera is characterized by a 120-bp deletion in exon 35 of TNXB and results in TNXB haploinsufficiency and disrupted TGF-β signaling; when found in the homozygous state, it leads to a contiguous gene syndrome consisting of CAH and Ehlers-Danlos syndrome (EDS) [7, 31].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“This rare chimera is characterized by a 120-bp deletion in exon 35 of TNXB and results in TNXB haploinsufficiency and disrupted TGF-β signaling; when found in the homozygous state, it leads to a contiguous gene syndrome consisting of CAH and Ehlers-Danlos syndrome (EDS) [7, 31].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“This rare chimera is characterized by a 120-bp deletion in exon 35 of TNXB and results in TNXB haploinsufficiency and disrupted TGF-β signaling; when found in the homozygous state, it leads to a contiguous gene syndrome consisting of CAH and Ehlers-Danlos syndrome (EDS) [7, 31].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“Skin biopsy of this patient showed small collagen fibers of normal shape and a complete absence of tenascin XB (TNX).Cultured dermal fibroblasts also lacked TNX.”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Burch et al. [1997]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A., & Sakakura, T. (1986) · Cell · doi:10.1016/0092-8674(86)90374-0 · Cited by 992
Mice develop normally without tenascin.
Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T., & Aizawa, S. (1992) · Genes & Development · doi:10.1101/gad.6.10.1821 · Cited by 582
A Heritable Disorder of Connective Tissue: Hydroxylysine-Deficient Collagen Disease
Pinnell, S. R., Krane, S. M., Kenzora, J. E., & Glimcher, M. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197205112861901 · Cited by 414
Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions
Erickson, H. P. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90037-q · Cited by 399
Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Self-citationA six-armed oligomer isolated from cell surface fibronectin preparations
Erickson, H. P., & Inglesias, J. L. (1984) · Nature · doi:10.1038/311267a0 · Cited by 274
Skin wounds and severed nerves heal normally in mice lacking tenascin-C.
Forsberg, E., Hirsch, E., Fröhlich, L., Meyer, M., Ekblom, P., Aszodi, A., Werner, S., & Fässler, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6594 · Cited by 235
Characterization of frequent deletions causing steroid 21-hydroxylase deficiency
White, P. C., Vitek, A., Dupont, B., & New, M. I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4436 · Cited by 229
Fuss, B., Wintergerst, E. S., Bartsch, U., & Schachner, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.5.1237 · Cited by 177
Jones, F. S., Burgoon, M. P., Hoffman, S., Crossin, K. L., Cunningham, B. A., & Edelman, G. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2186 · Cited by 176
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
“One kindred carries an unusual deletion extending into the TNXB gene; the patients in this kindred have a contiguous gene syndrome including 21-hydroxylase deficiency and a form of Ehlers-Danlos syndrome caused by loss of function of tenascin-X (449).”
BackgroundThe myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
“skin [158,159].”
Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators
Kadler, K. E., Hill, A., & Canty-Laird, E. G. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.06.008 · Cited by 756
“The gene for tenascin-X was the first EDS gene not to encode a fibrillar collagen or procollagen processing enzyme [61].”
BackgroundChakravarti, S., Magnuson, T., Lass, J. H., Jepsen, K. J., LaMantia, C., & Carroll, H. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1277 · Cited by 731
“Mutations in lumican and other LRPs will fall in this last category, which includes recent detection of mutations in COL5A1 gene (42) and Tenascin-X (3).”
BackgroundForm and function: The laminin family of heterotrimers
Colognato, H., & Yurchenco, P. D. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200006)218:2<213::aid-dvdy1>3.0.co;2-r · Cited by 1,244
Jones, F. S., & Jones, P. L. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200006)218:2<235::aid-dvdy2>3.0.co;2-g · Cited by 690
“Consistent with an essential role for TN-X in development, deletions within the TN-X gene results in Ehlers-Danlos Syndrome, a connective tissue disorder involving skin and joint hyperextensibility, vascular fragility, and poor wound healing (Burch et al., 1997).”
BackgroundCongenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationTenascins: regulation and putative functions during pathological stress
Chiquet‐Ehrismann, R., & Chiquet, M. (2003) · The Journal of Pathology · doi:10.1002/path.1415 · Cited by 549
“This patient suffered from skin and joint hyperextensibility, vascular fragility, and poor wound healing [21].”
BackgroundDermatan sulfate: new functions from an old glycosaminoglycan
Trowbridge, J. M., & Gallo, R. L. (2002) · Glycobiology · doi:10.1093/glycob/cwf066 · Cited by 457
“Interestingly, patients deficient in tenascin-X and mice deficient in decorin both have increased skin fragility (Burch et al., 1997; Danielson et al., 1997).”
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Self-citationRevisiting the matricellular concept
Murphy-Ullrich, J. E., & Sage, E. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.07.005 · Cited by 392
“Tenascin-X deficiency is associated with the Ehlers–Danlos syndrome (Burch et al., 1997; Schalkwijk et al., 2001).”
BackgroundEhlers-Danlos syndrome type IV
Germain, D. P. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-32 · Cited by 376
Colige, A., Sieron, A. L., Li, S.-W., Schwarze, U., Petty, E., Wertelecki, W., Wilcox, W., Krakow, D., Cohn, D. H., Reardon, W., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302504 · Cited by 370
“Mutations in the genes encoding a1(I), a2(I), a1(III), a1(V), and a2(V) chains of procollagens, lysyl hydroxylase, and tenascin-X have been found in different forms of EDS (Levinson et al. 1993; Steinmann et al. 1993; Toriello et al. 1996; Wenstrup et al. 1996; Burch et al. 1997; De Paepe et al. 1997).”
BackgroundNataatmadja, M., West, M., West, J., Summers, K., Walker, P., Nagata, M., & Watanabe, T. (2003) · Circulation · doi:10.1161/01.cir.0000087660.82721.15 · Cited by 354
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Haubeck, H.-D. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_2980 · Cited by 330
Malfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 316
Tenascin-C in development and disease: gene regulation and cell function
Jones, P. L., & Jones, F. S. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00106-2 · Cited by 319
Tenascins and the Importance of Adhesion Modulation
Chiquet-Ehrismann, R., & Tucker, R. P. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004960 · Cited by 272
“The first morphological tenascin knockout phenotype came not from the mouse, but from a human: a 26-year-old man with EhlersDanlos Syndrome was shown to have a mutation that resulted in the loss of expression of tenascin-X (Burch et al. 1997).”
BackgroundThe Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 258
“The authors concluded that a small deletion or missense mutation had probably remained undetected on the maternal allele [Burch et al., 1997].”
BackgroundWeber, P., Bartsch, U., Rasband, M. N., Czaniera, R., Lang, Y., Bluethmann, H., Margolis, R. U., Levinson, S. R., Shrager, P., Montag, D., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04245.1999 · Cited by 247
“Copyright © 1999 Society for Neuroscience 0270-6474/99/194245-18$05.00/0 Danlos syndrome has been discovered recently (Burch et al., 1997).”
BackgroundInfluentialGenomic Organization of the Mammalian Mhc
Kumánovics, A., Takada, T., & Lindahl, K. F. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.090501.080116 · Cited by 247
Haploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome
Zweers, M. C., Bristow, J., Steijlen, P. M., Dean, W. B., Hamel, B. C., Otero, M., Kucharekova, M., Boezeman, J. B., & Schalkwijk, J. (2003) · The American Journal of Human Genetics · doi:10.1086/376564 · Cited by 242
Self-citationMao, J. R., Taylor, G., Dean, W. B., Wagner, D. R., Afzal, V., Lotz, J. C., Rubin, E. M., & Bristow, J. (2002) · Nature Genetics · doi:10.1038/ng850 · Cited by 261
Self-citationBradshaw, A. D., Puolakkainen, P., Wight, T. N., Helene Sage, E., Dasgupta, J., & Davidson, J. M. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12241.x · Cited by 238
“Moreover, mutations in tenascin X have been implicated in a form of Ehlers^Danlos syndrome (Burch et al, 1997), and result in diminished deposition of collagen in the skin (Mao et al, 2002).”
BackgroundPain in Ehlers-Danlos Syndrome Is Common, Severe, and Associated with Functional Impairment
Voermans, N. C., Knoop, H., Bleijenberg, G., & van Engelen, B. G. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.12.026 · Cited by 237
The Ehlers-Danlos syndrome: on beyond collagens
Mao, J.-R., & Bristow, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12881 · Cited by 233
“Whether TNX triggers intracellular signaling events or alters synthesis of specific matrix components is unknown, but the index patient’s fibroblasts appear to synthesize collagen I and collagen V normally (26).”
BackgroundSelf-citationOverview of Wound Healing and Management
Childs, D. R., & Murthy, A. S. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.08.013 · Cited by 230
“There are 6 major types of Ehlers-Danlos and all but 1 is a heritable disorder of collagen, the exception being a heritable disorder of tenascin.(25,26) It is an autosomal dominant condition often associated with mitral valve prolapse.”
BackgroundLincoln, J., Lange, A. W., & Yutzey, K. E. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.03.027 · Cited by 231
Gubbiotti, M. A., Vallet, S. D., Ricard-Blum, S., & Iozzo, R. V. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.09.009 · Cited by 227
Castori, M. (2012) · ISRN Dermatology · doi:10.5402/2012/751768 · Cited by 222
Aortic valve disease and treatment: The need for naturally engineered solutions
Butcher, J. T., Mahler, G. J., & Hockaday, L. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.008 · Cited by 210
“Mutations in COL1A1, COL3A1, COL1A2, COL5A1, and tenascin-x (TNX) have all be associatedwith the disease; although COL5A1 mutations have been shown to cause the classical forms (EDS types I and II) of Ehlers–Danlos Syndrome [253,254].”
BackgroundTendon and ligament: Development, repair and disease
Tozer, S., & Duprez, D. (2005) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20049 · Cited by 187
Yang, Z., Mendoza, A. R., Welch, T. R., Zipf, W. B., & Yu, C. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12147 · Cited by 184
Schwarze, U., Hata, R.-I., McKusick, V. A., Shinkai, H., Hoyme, H. E., Pyeritz, R. E., & Byers, P. H. (2004) · The American Journal of Human Genetics · doi:10.1086/420794 · Cited by 180
“Mutations in the COL5A2 gene (Michalickova et al. 1998; Richards et al. 1998), the tenascin X gene (TNXB [MIM 606408]) (Burch et al. 1997; Schalkwijk et al. 2001), and the gene that encodes Received December 19, 2003; accepted for publication February 25, 2004; electronically published April 9,…”
BackgroundNakayama, R., Nemoto, T., Takahashi, H., Ohta, T., Kawai, A., Seki, K., Yoshida, T., Toyama, Y., Ichikawa, H., & Hasegawa, T. (2007) · Modern Pathology · doi:10.1038/modpathol.3800794 · Cited by 178
Meet the Tenascins: Multifunctional and Mysterious
Hsia, H. C., & Schwarzbauer, J. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500005200 · Cited by 176
Oestreicher, J. L., Walters, I. B., Kikuchi, T., Gilleaudeau, P., Surette, J., Schwertschlag, U., Dorner, A. J., Krueger, J. G., & Trepicchio, W. L. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500067 · Cited by 174
Fatigue Is a Frequent and Clinically Relevant Problem in Ehlers-Danlos Syndrome
Voermans, N. C., Knoop, H., van de Kamp, N., Hamel, B. C., Bleijenberg, G., & van Engelen, B. G. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2009.08.003 · Cited by 170
Classical Ehlers-Danlos Syndrome Caused by a Mutation in Type I Collagen
Nuytinck, L., Freund, M., Lagae, L., Pierard, G. E., Hermanns-Le, T., & De Paepe, A. (2000) · The American Journal of Human Genetics · doi:10.1086/302859 · Cited by 169
“…recent studies, including knock-out experiments, suggest that other connectivetissue components, such as decorin (Danielson et al. 1997), thrombospondin-2 (Kyriakides et al. 1998), lumican (Chakravarti et al. 1998), and tenascin-X (Burch et al. 1997), may be causally involved in classical EDS.”
BackgroundNeuromuscular involvement in various types of Ehlers–Danlos syndrome
Voermans, N. C., van Alfen, N., Pillen, S., Lammens, M., Schalkwijk, J., Zwarts, M. J., van Rooij, I. A., Hamel, B. C. J., & van Engelen, B. G. (2009) · Annals of Neurology · doi:10.1002/ana.21643 · Cited by 168
“The clinical features of all TNXdeficient type EDS patients were similar to those described previously.(3,4) TNX in serum was less than 0.”
BackgroundMethodGensemer, C., Burks, R., Kautz, S., Judge, D. P., Lavallee, M., & Norris, R. A. (2021) · Developmental Dynamics · doi:10.1002/dvdy.220 · Cited by 149
“Some patients with CAH will have a mutation or deletion in CYP21A2 that also affects TNXB, leading to contiguous deletion syndrome (CAH-X).(236) TNXA/TNXB chimeras have been identified in which TNXB exons are replaced with TNXA.”
BackgroundLoss of Dermatan-4-Sulfotransferase 1 Function Results in Adducted Thumb-Clubfoot Syndrome
Dündar, M., Müller, T., Zhang, Q., Pan, J., Steinmann, B., Vodopiutz, J., Gruber, R., Sonoda, T., Krabichler, B., Utermann, G., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.11.010 · Cited by 131
“Loss of tenascin-X results in a form of EDS with skin and joint hypermobility and poor wound healing (MIM 606408).(40) Decreased TNX binding might be responsible for the occurrence of features resembling TNX deficiency in ATCS patients.”
BackgroundSchwarze, U., Atkinson, M., Hoffman, G. G., Greenspan, D. S., & Byers, P. H. (2000) · The American Journal of Human Genetics · doi:10.1086/302933 · Cited by 136
“1996) and by the identification of a deletion of one allele of tenascin X, adjacent to the 21-hydroxylase gene (Burch et al. 1997), in an adolescent with EDS and 21-hydroxylase deficiency.”
BackgroundTenascin-X: beyond the architectural function
Valcourt, U., Alcaraz, L. B., Exposito, J.-Y., Lethias, C., & Bartholin, L. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994893 · Cited by 132
“An ultrastructural analysis of skin from TN-X-deficient patients and mice revealed that the morphology of collagen fibrils was regular,47,54 in contrast to the irregular shapes of collagen fibrils observed in the classic and hypermobility forms of EDS.55 The most striking feature was an increased distance between fibr…”
BackgroundInfluentialColombi, M., Dordoni, C., Chiarelli, N., & Ritelli, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31429 · Cited by 127
“The patients with the 30 kb deletion in homozygosity [Burch et al., 1997], or in compound heterozygosity with a second CYP21A2mutation [Mercke et al., 2013], also present with congenital adrenal hyperplasia (CAH).”
BackgroundCOL5A1 Haploinsufficiency Is a Common Molecular Mechanism Underlying the Classical Form of EDS
WENSTRUP, R. J., Florer, J. B., Willing, M. C., Giunta, C., Steinmann, B. U., Young, F., Susic, M., & Cole, W. G. (2000) · The American Journal of Human Genetics · doi:10.1086/302930 · Cited by 128
“Also, a heritable deficiency of tenascin X in humans results in an EDS-like phenotype with recessive inheritance (Burch et al. 1997a, 1997b).”
BackgroundModulation of collagen fibrillogenesis by tenascin-X and type VI collagen
Minamitani, T., Ikuta, T., Saito, Y., Takebe, G., Sato, M., Sawa, H., Nishimura, T., Nakamura, F., Takahashi, K., Ariga, H., et al. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.030 · Cited by 138
Xie, T., Rowen, L., Aguado, B., Ahearn, M. E., Madan, A., Qin, S., Campbell, R. D., & Hood, L. (2003) · Genome Research · doi:10.1101/gr.1736803 · Cited by 144
“…adrenal hyperplasia, which is associated with mutations in the cytochrome P450 CYP21A2 gene that is required for cortisol biosynthesis (Chiou et al. 1990), and Ehlers-Danlos Syndrome, a connective tissue disorder of which one variant is caused by mutations in tenascin X (TNX; Burch et al. 1997).”
BackgroundAnalysis of collagen-interacting proteins in patients with incisional hernias
Rosch, R., Junge, K., Knops, M., Lynen, P., Klinge, U., & Schumpelick, V. (2003) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-002-0345-3 · Cited by 122
“Deletions within the TN-X gene results in Ehlers-Danlos syndrome [28].”
BackgroundTenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome
Bristow, J., Carey, W., Egging, D., & Schalkwijk, J. (2005) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30071 · Cited by 123
“While the number remains small [Burch et al., 1997; Schalkwijk et al., 2001; Lindor and Bristow, 2005], several generalizations about the clinical features can be made.”
BackgroundSelf-citationStenger, J. E., Lobachev, K. S., Gordenin, D. A., Darden, T. A., Jurka, J., & Resnick, M. A. (2001) · Genome Research · doi:10.1101/gr.158801 · Cited by 123
“…(associated with an undesignated Ehlers-Danlos syndrome type, clinically similar to type II, but with distinct ultrastructural characteristics) (Burch et al. 1997), MeCP2, encoding x-linked methyl-CpG-binding protein (Rett syndrome) (Amir et al. 1999) and GPC3, associated with…”
BackgroundMalfait, F., & Paepe, A. D. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7893-1_9 · Cited by 137
Transcriptional regulation of tenascin genes
Chiovaro, F., Chiquet‐Ehrismann, R., & Chiquet, M. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1008333 · Cited by 129
“However, a fraction of cases with deletions in this genomic region are also deficient for TNX; these patients suffer in addition from hyperextensible skin and joint laxity typical of Ehlers-Danlos syndrome.(116,118,119) The MHCIII gene locus is very complex and has been partly duplicated resulting in 2 TNX gene copies…”
BackgroundMaller, O., Martinson, H. A., & Schedin, P. S. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9189-6 · Cited by 154
Fikree, A., Aktar, R., Grahame, R., Hakim, A. J., Morris, J. K., Knowles, C. H., & Aziz, Q. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12535 · Cited by 117
Vascular aspects of the Ehlers-Danlos Syndromes
Malfait, F. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.013 · Cited by 113
Binding of tenascin‐X to decorin
Elefteriou, F., Exposito, J.-Y., Garrone, R., & Lethias, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02361-4 · Cited by 112
Wilson, R., Norris, E. L., Brachvogel, B., Angelucci, C., Zivkovic, S., Gordon, L., Bernardo, B. C., Stermann, J., Sekiguchi, K., Gorman, J. J., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014159 · Cited by 115
“in skin and muscle (42, 43), raising the possibility of a similar”
BackgroundMutations in the collagen XII gene define a new form of extracellular matrix-related myopathy
Hicks, D., Farsani, G. T., Laval, S., Collins, J., Sarkozy, A., Martoni, E., Shah, A., Zou, Y., Koch, M., Bonnemann, C. G., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt637 · Cited by 111
Takahara, K., Schwarze, U., Imamura, Y., Hoffman, G. G., Toriello, H. V., Smith, L. T., Byers, P. H., & Greenspan, D. S. (2002) · The American Journal of Human Genetics · doi:10.1086/342099 · Cited by 117
“2001), and tenascin X (TNX) (Burch et al. 1997; Schalkwijk et al. 2001) genes.”
BackgroundSelf-citationFikree, A., Grahame, R., Aktar, R., Farmer, A. D., Hakim, A. J., Morris, J. K., Knowles, C. H., & Aziz, Q. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.014 · Cited by 104
Collagen XII Interacts with Avian Tenascin-X through Its NC3 Domain
Veit, G., Hansen, U., Keene, D. R., Bruckner, P., Chiquet-Ehrismann, R., Chiquet, M., & Koch, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603147200 · Cited by 104
Targeted Disruption of Dermatopontin Causes Abnormal Collagen Fibrillogenesis
Takeda, U., Utani, A., Wu, J., Shinkai, H., Adachi, E., Koseki, H., Taniguchi, M., MATSUMOTΟ, T., OHASHI, T., & Sato, M. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01863.x · Cited by 112
Müller, T., Mizumoto, S., Suresh, I., Komatsu, Y., Vodopiutz, J., Dundar, M., Straub, V., Lingenhel, A., Melmer, A., Lechner, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt227 · Cited by 104
“The phenotypic overlap of MCEDS and the tenascin-X (TNX [MIM 600985])-deficient form of EDS (MIM 606408) (64) might be caused by a disruption of extracellular binding of decorin and tenascin-X, which also binds to tropoelastin and collagen types I, III, V, XII and XIV (65,66).”
BackgroundHigh Precision Platelet Releasate Definition by Quantitative Reversed Protein Profiling—Brief Report
Wijten, P., van Holten, T. C., Woo, L. L., Bleijerveld, O. B., Roest, M., Heck, A. J. R., & Scholten, A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301147 · Cited by 103
“For example, Follistatin-like protein 1 has been found in osteoblasts and fibroblasts and characterized to play a role in the inflammatory pathway(20); filamin C plays a role in the crosslinking of actin in muscle cells(21); and tenascin-X binds to several collagen subtypes and plays a role in wound healing, as shown…”
BackgroundFlück, M., Tunç-Civelek, V., & Chiquet, M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3583 · Cited by 113
Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury
Carey, W. A., Taylor, G. D., Dean, W. B., & Bristow, J. D. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00385.2009 · Cited by 100
Self-citationCONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY
Speiser, P. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70018-5 · Cited by 110
Severe Osteogenesis Imperfecta in Cyclophilin B–Deficient Mice
Choi, J. W., Sutor, S. L., Lindquist, L., Evans, G. L., Madden, B. J., Bergen, H. R., Hefferan, T. E., Yaszemski, M. J., & Bram, R. J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000750 · Cited by 98
“Mouse embryonic fibroblasts (MEFs) or skin fibroblasts were generated as previously described [45].”
MethodThe yin and yang of tenascin-R in CNS development and pathology
Pesheva, P., & Probstmeier, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00061-1 · Cited by 102
Joint hypermobility syndromes: The pathophysiologic role of tenascin‐X gene defects
Zweers, M. C., Hakim, A. J., Grahame, R., & Schalkwijk, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20488 · Cited by 91
Disorders of Connective Tissue
Burrows, N., & Lovell, C. R. (2004) · Wiley eBooks · doi:10.1002/9780470750520.ch46 · Cited by 94
Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review
D'hondt, S., Van Damme, T., & Malfait, F. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.138 · Cited by 90
Clinical and molecular overlap between myopathies and inherited connective tissue diseases
Voermans, N. C., Bönnemann, C. G., Huijing, P. A., Hamel, B. C. J., Kuppevelt, T. H. V., HAAN, A. D., Schalkwijk, J., van Engelen, B. G. M., & Jenniskens, G. J. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.05.017 · Cited by 100
“Deficiency of tenascin-X results in a phenotype similar to the classical type of Ehlers-Danlos syndrome, but with a recessive inheritance and lack of skin fragility [68,69].”
Sinibaldi, L., Ursini, G., & Castori, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31430 · Cited by 87
“…an ECM glycoprotein involved in the organization and maintenance of the connective tissue structure [Petersen and Douglas, 2013], has been linked to both autosomal dominant and autosomal recessive EDS [Burch et al., 1997; Schalkwijk et al., 2001; Zweers et al., 2003, 2005; Voermans et al., 2009].”
BackgroundComparative anatomy and ontogeny of the ductus arteriosus, a vascular outsider
Bergwerff, M., DeRuiter, M. C., & Groot, A. C. G. (1999) · Anatomy and Embryology · doi:10.1007/s004290050304 · Cited by 86
Mosher, D. F., & Adams, J. C. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.01.003 · Cited by 95
Deficiency of Tenascin-X Causes Abnormalities in Dermal Elastic Fiber Morphology
Zweers, M. C., van Vlijmen-Willems, I. M., Kuppevelt, T. H. V., Mecham, R. P., Steijlen, P. M., Bristow, J., & Schalkwijk, J. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22401.x · Cited by 95
Self-citationMerke, D. P., Chen, W., Morissette, R., Xu, Z., Van Ryzin, C., Sachdev, V., Hannoush, H., Shanbhag, S. M., Acevedo, A. T., Nishitani, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3148 · Cited by 82
Early Aldosterone-Regulated Genes in Cardiomyocytes: Clues to Cardiac Remodeling?
Fejes‐Tóth, G., & Náray‐Fejes‐Tóth, A. (2007) · Endocrinology · doi:10.1210/en.2006-1438 · Cited by 91
Ikuta, T., Ariga, H., & Matsumoto, K. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00376.x · Cited by 81
“However, a patient with both 21-hydroxylase deficiency and Ehlers±Danlos syndrome had an internal deletion including the C-terminal region of TNX, all of CYP21B and C4B genes (Burch et al. 1997).”
BackgroundA single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II.
Richards, A. J., Martin, S., Nicholls, A. C., Harrison, J. B., Pope, F. M., & Burrows, N. P. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.10.846 · Cited by 79
“Two other candidate genes for EDS I/II are those which code for decorin'9 and tenascin X.20 In sporadic cases of EDS I/I, or small families in which exclusion of candidate genes is not possible, variation in clinical signs may provide important clues for determining which gene is mutated.”
BackgroundDemidova‐Rice, T. N., Geevarghese, A., & Herman, I. M. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00642.x · Cited by 76
“That tenascin X is present within the anticollagen I IPs is of particular interest since this matrix component has been previously implicated in soft tissue injury and repair in humans.(34,35) Using both 2- and 3D models, we found that the peptides released from the ECM by Clostridial collagenase induce key wound heal…”
BackgroundA model of tenascin-X integration within the collagenous network
Lethias, C., Carisey, A., Comte, J., Cluzel, C., & Exposito, J.-Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.037 · Cited by 74
“Ultrastructural analyses reveal abnormalities in collagen fibril networks and elastic fibres [2,4].”
BackgroundTNXB Mutations Can Cause Vesicoureteral Reflux
Gbadegesin, R. A., Brophy, P. D., Adeyemo, A., Hall, G., Gupta, I. R., Hains, D., Bartkowiak, B., Rabinovich, C. E., Chandrasekharappa, S., Homstad, A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121148 · Cited by 72
Bader, H. L., Keene, D. R., Charvet, B., Veit, G., Driever, W., Koch, M., & Ruggiero, F. (2008) · Matrix Biology · doi:10.1016/j.matbio.2008.09.580 · Cited by 79
Gene regulation by mechanotransduction in fibroblasts
Chiquet, M., Tunç-Civelek, V., & Sarasa-Renedo, A. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-053 · Cited by 69
“In humans, the latter member of the tenascin family is implicated in the EhlersDanlos syndrome (Burch et al. 1997).”
BackgroundBroadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia
Morissette, R., Chen, W., Perritt, A. F., Dreiling, J. L., Arai, A. E., Sachdev, V., Hannoush, H., Mallappa, A., Xu, Z., McDonnell, N. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2232 · Cited by 68
“To rule out possible pathogenic variants in other known EDS associated genes, we sequenced the COL3A1, COL5A1, and COL5A2 genes in the 10 novel CAH-X patients and found no pathogenic or likely pathogenic variants.”
BackgroundInfluentialEhlers–Danlos syndrome: A showcase of conditions that lead to understanding matrix biology
Byers, P. H., & Murray, M. L. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.07.005 · Cited by 68
“Deficiency of tenascin X was the first non-collagen or collagen-modifier implicated to cause a form of EDS (Burch et al., 1997).”
BackgroundTenascin‐X deficiency in autosomal recessive Ehlers–Danlos syndrome
Lindor, N. M., & Bristow, J. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30671 · Cited by 67
“Subsequently, a patient was found to have a contiguous gene deletion syndrome with congenital adrenal hyperplasia due to 21- hydroxylase deficiency and a ‘‘classical’’ Ehlers–Danlos phenotype [Burch et al., 1997].”
BackgroundMethodSelf-citationMyelination and behaviour of tenascin‐C null transgenic mice
Kiernan, B. W., Garcion, E., Ferguson, J., Frost, E. E., Torres, E. M., Dunnett, S. B., Saga, Y., Aizawa, S., Faissner, A., Kaur, R., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00729.x · Cited by 67
“Another possible compensatory tenascin is tenascin-X, de®ciency of which in humans has been associated with one form of the connective tissue abnormality Ehlers±Danlos syndrome (Burch et al., 1997).”
BackgroundMolecular Genetics of the Human MHC Complement Gene Cluster
Yu, C. Y. (1998) · Experimental and Clinical Immunogenetics · doi:10.1159/000019075 · Cited by 67
Interactions of human tenascin-X domains with dermal extracellular matrix molecules
Egging, D. F., van den Berkmortel, F., Taylor, G. D., Bristow, J., & Schalkwijk, J. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0706-9 · Cited by 70
Self-citationThe Genetics of Soft Connective Tissue Disorders
Vanakker, O., Callewaert, B., Malfait, F., & Coucke, P. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-050039 · Cited by 66
Molecular Genetics of 21- Hydroxylase Deficiency
Wedell, A. (2011) · Endocrine Development · doi:10.1159/000321223 · Cited by 64
Matricellular proteins in the trabecular meshwork
Rhee, D. J., Haddadin, R. I., Kang, M. H., & Oh, D. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.11.032 · Cited by 66
Metadata
- Authors
- Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J.
- Affiliations
- University of California, San Francisco (US)
- Children's Hospital Central California (US)
- University of Washington (US)
- Corresponding author
- Bristow, James
- Venue
- Nature Genetics
- Published
- 1997-09
- Volume
- 17
- Issue
- 1
- Pages
- 104-108
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1989696897
- Semantic Scholar
- 875064e9bae6e7e062e9583a6639eb0ce870bd3b
- Cited by
- 366
- References
- 31
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 17 · 2020: 13 · 2019: 10 · 2018: 11 · 2017: 10 · 2016: 10 · 2015: 15 · 2014: 10 · 2013: 17 · 2012: 13
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl002695-02)
- National Heart, Lung, and Blood Institute (HL 02695)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-37922, R01DK037922)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- tenascin-X, Ehlers-Danlos syndrome, contiguous gene syndrome, 21-hydroxylase deficiency, connective tissue diseases, skin hyperextensibility, vascular fragility, delayed wound healing, recessive inheritance, extracellular matrix proteins, dermal fibroblasts
- MeSH terms
- Adult, Alleles, Biopsy, Cells, Cultured, Ehlers-Danlos Syndrome, Female, Fibroblasts, Humans, Male, Pedigree, Skin, Polymerase Chain Reaction, Sequence Deletion, Tenascin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.